$AEZS Recent News Canada hot stocks Hudson's B

$AEZS Recent News

Canada hot stocks Hudson's Bay, Fiera, Maple Leaf 8:57 a.m. Dec. 11, 2012 - MarketWatch.com
Canada hot stocks: Pilot Gold, AEterna, OceanaGold 1:12 p.m. Oct. 12, 2012 - MarketWatch.com
Aeterna Zentaris prices offering at 20% discount 10:00 a.m. Oct. 12, 2012 - MarketWatch.com
AEterna Zentaris down 18% in premarket trades 6:48 a.m. Oct. 12, 2012 - Steve Gelsi
Aeterna Zentaris consolidates shares 6 to 1 7:10 a.m. Oct. 3, 2012 - MarketWatch.com
Canada hot stocksrogress ,Lake Shore Gold 1:23 p.m. April 2, 2012 - MarketWatch
Keryx, AEterna implode on failed drug study 10:13 a.m. April 2, 2012 - Val Brickates Kennedy
Research in Motion active; Hitachi at 52-week high 9:14 a.m. April 2, 2012 - blogs.marketwatch.com
Keryx, AEterna rally ahead of study results 12:34 p.m. March 16, 2012 - Val Brickates Kennedy
AEterna, Keryx soar on study speculation 12:52 p.m. March 5, 2012 - Val Brickates Kennedy
Canada hot stocks to watch: Intact, Afexa, AETerna 8:31 a.m. Sept. 26, 2011 - MarketWatch.com
Canada hot stocks: Cameco, Hathor, Air Canada 9:08 a.m. Sept. 14, 2011 - MarketWatch
Canada hot stocks: Couche-Tard, Vitran, Rubicon 1:28 p.m. July 12, 2011 - MarketWatch
Canada hot stocks to watch: Trican, Provident 8:18 a.m. July 12, 2011 - MarketWatch.com
Drug stocks slip on Fed comments 2:08 p.m. July 14, 2010 - Val Brickates Kennedy
AEterna, Metabolix in spotlight 12:03 p.m. May 12, 2010 - Val Brickates Kennedy
InterMune rebounds; AEterna rallies 9:40 a.m. May 6, 2010 - Val Brickates Kennedy
AEterna falls; Inspire, Rexahn rally 2:15 p.m. April 16, 2010 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:29 p.m. April 13, 2010 - MarketWatch
Xoma rallies on patents; Orexigen slides 9:19 a.m. April 13, 2010 - Val Brickates Kennedy


Aeterna Zentaris slammed after FDA rejection 23 min ago - Seeking Alpha
Update: AEterna Zentaris Q3 2014 Earnings 4:58 a.m. Today - Seeking Alpha
Aeterna Zentaris' (AEZS) CEO David Dodd on Q3 2014 Results - Earnings Call Transcript 6:30 p.m. Nov. 5, 2014 - Seeking Alpha
PDUFA date today for Aeterna's macimorelin acetate 12:02 p.m. Nov. 5, 2014 - Seeking Alpha
AEterna Zentaris: The Bear Case In Front Of The November 5th PDUFA 8:24 a.m. Oct. 30, 2014 - Seeking Alpha
Bearish behavior from AEterna Zentaris ahead of PDUFA 10:27 a.m. Oct. 14, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 3:03 p.m. Sept. 25, 2014 - Seeking Alpha
AEterna Zentaris Has A Great Value Proposition - CEO David Dodd Explains Why 9:19 a.m. Sept. 23, 2014 - Seeking Alpha
Aeterna Zentaris: A Risk Worth Taking 12:54 p.m. Sept. 9, 2014 - Seeking Alpha
Aeterna Zentaris' (AEZS) CEO David Dodd on Q2 2014 Results - Earnings Call Transcript 4:20 p.m. Aug. 8, 2014 - Seeking Alpha
12 Analyst Stocks to Buy Under $10 With Huge Potential Upside 7:24 a.m. July 19, 2014 - 247WallSt.com
Basket Of Biotech Bargains To Buy And Hold 3:23 p.m. June 30, 2014 - Seeking Alpha
Aeterna Zentaris downsizes 28% 11:32 a.m. June 10, 2014 - Seeking Alpha
Aeterna Zentaris' (AEZS) CEO David Dodd on Q1 2014 Results - Earnings Call Transcript 1:40 p.m. May 9, 2014 - Seeking Alpha
Aeterna Zentaris to set up shop in South Carolina 6:55 a.m. May 5, 2014 - Seeking Alpha
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 11:26 a.m. March 24, 2014 - Seeking Alpha
Æterna Zentaris CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:48 a.m. March 21, 2014 - Seeking Alpha
Aeterna Zentaris prices offering at $1.20/unit 9:22 a.m. Jan. 9, 2014 - Seeking Alpha
Update on Coronado's TSO - Analyst Blog 4:45 p.m. Dec. 16, 2013 - Zacks.com
Endocyte Enrolls First Patient in Study - Analyst Blog 6:27 p.m. Dec. 13, 2013 - Zacks.com


FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone Deficiency 7:00 a.m. Today - PR Newswire - PRF
Morning Briefing on Biotech Stocks - Arrowhead Research, Array BioPharma, Aegerion Pharma, Hemispherx Biopharma, and Aeterna Zentaris 8:30 a.m. Nov. 5, 2014 - PR Newswire - PRF
Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on November 4, 2014 6:30 a.m. Oct. 28, 2014 - PR Newswire - PRF
Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGelœ 6:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
Aeterna Zentaris Appoints Phil Theodore as Chief Administrative Officer, General Counsel and Corporate Secretary 6:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 7:50 a.m. Sept. 30, 2014 - PR Newswire - PRF
Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York 3:15 p.m. Sept. 2, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
Aeterna Zentaris to Present at Upcoming Canaccord Genuity 34th Annual Global Growth Conference in Boston 6:30 a.m. Aug. 6, 2014 - PR Newswire - PRF
Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market 6:30 a.m. Aug. 5, 2014 - PR Newswire - PRF
Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma 7:40 a.m. July 23, 2014 - PR Newswire - PRF
SCRA Announces First Tenant for Nexton Property 12:10 p.m. July 7, 2014 - BusinessWire - BZX
Aeterna Zentaris to Present at Upcoming Bloom Burton & Co. Healthcare Investor Conference in Toronto 6:30 a.m. June 11, 2014 - PR Newswire - PRF
Aeterna Zentaris Implements Global Resources Optimization Program as Part of its Transition into a Commercially Operating Specialty Biopharmaceutical Company 6:30 a.m. June 10, 2014 - PR Newswire - PRF
Aeterna Zentaris: Poster Presented at ASCO Meeting on the Design of the Current ZoptEC Phase 3 Trial in Endometrial Cancer 6:30 a.m. June 2, 2014 - PR Newswire - PRF
Aeterna Zentaris: Poster to be Presented on the Design of Current ZoptEC Phase 3 Trial in Endometrial Cancer with Zoptarelin Doxorubicin at ASCO 6:30 a.m. May 22, 2014 - PR Newswire - PRF
Aeterna Zentaris Announces Board of Directors Leadership Change and Election of Directors at Annual Meeting of Shareholders 6:30 a.m. May 12, 2014 - PR Newswire - PRF
Aeterna Zentaris Announces At the Market Issuance Program 3:15 p.m. May 9, 2014 - PR Newswire - PRF
Aeterna Zentaris Selects Charleston, S.C. as New Location for its North American Business and Global Commercial Operations 6:30 a.m. May 5, 2014 - PR Newswire - PRF
Aeterna Zentaris to Announce First Quarter 2014 Financial and Operating Results on May 8, 2014 and Hold Annual Shareholders Meeting on May 9, 2014 6:30 a.m. April 30, 2014 - PR Newswire - PRF